Screener
National Research Corporation NRC Q2 2026 earnings
Reported July 28, 2026 · After market close
Revenue$35.4MBeat by $492.0K
EPS$0.31Beat by $0.46
Revenue estimate$34.9M
EPS estimate-$0.15
“As healthcare organizations increasingly seek partners who can help improve experience outcomes, strengthen governance, and build enduring brand value, we believe NRC Health is uniquely differentiated through our three connected strengths: delivering continuous consumer and patient insights, providing trusted partnership and strategic engagement with healthcare leaders, and enabling actions that lead to improved outcomes.”
Next report
Feb 2, 2027 (in 2 months)Revenue estimate$38.8M
EPS estimate$0.24
Financials
Q2 2026Valuation & ratios
Segments
By product
Versus estimates
Revenue
Q3 2026$38.4MBeat by $2.6M
Q2 2026$35.4MBeat by $492.0K
Q1 2026$34.8MQ4 2025$35.2MQ3 2025$34.6MQ2 2025$34.0MDiluted EPS
FAQ
- When did National Research Corporation report Q2 2026 earnings?
- National Research Corporation (NRC) reported Q2 2026 earnings on July 28, 2026 after market close.
- What were National Research Corporation's Q2 2026 revenue and EPS?
- National Research Corporation reported revenue of $35.4M and eps of $0.31 for Q2 2026.
- Did National Research Corporation beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $34.9M by $492.0K. EPS beat the consensus estimate of $-0.15 by $0.46.
- How did National Research Corporation's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 4.0% from $34.0M a year earlier and eps grew 10.7% from $0.28.
- Where can I find National Research Corporation's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001437749-26-024663) and the 10-Q periodic report (0001437749-26-025624) directly on SEC EDGAR. The filing index links above go to sec.gov.
